230 related articles for article (PubMed ID: 2064128)
1. Abnormalities of pathways of fibrin turnover in the human pleural space.
Idell S; Girard W; Koenig KB; McLarty J; Fair DS
Am Rev Respir Dis; 1991 Jul; 144(1):187-94. PubMed ID: 2064128
[TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
3. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
[TBL] [Abstract][Full Text] [Related]
4. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
5. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
Kemper P; Köhler D
Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
[TBL] [Abstract][Full Text] [Related]
6. The contribution of factor V to the coagulant property of pleural fluid.
Wyshock EG; Idell S; Colman RW
J Lab Clin Med; 1992 Nov; 120(5):726-34. PubMed ID: 1431501
[TBL] [Abstract][Full Text] [Related]
7. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
Chung CL; Yeh CY; Sheu JR; Chen YC; Chang SC
Am J Med Sci; 2007 Dec; 334(6):452-7. PubMed ID: 18091367
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition.
Idell S; James KK; Gillies C; Fair DS; Thrall RS
Am J Pathol; 1989 Aug; 135(2):387-99. PubMed ID: 2476934
[TBL] [Abstract][Full Text] [Related]
9. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.
Idell S; Peterson BT; Gonzalez KK; Gray LD; Bach R; McLarty J; Fair DS
Am Rev Respir Dis; 1988 Nov; 138(5):1282-94. PubMed ID: 3202484
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury.
Tucker T; Idell S
Semin Thromb Hemost; 2013 Jun; 39(4):373-81. PubMed ID: 23504608
[TBL] [Abstract][Full Text] [Related]
11. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
12. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.
Idell S; Peters J; James KK; Fair DS; Coalson JJ
J Clin Invest; 1989 Jul; 84(1):181-93. PubMed ID: 2738151
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic and inflammatory processes in pleural effusions.
Philip-Joët F; Alessi MC; Philip-Joët C; Aillaud M; Barriere JR; Arnaud A; Juhan-Vague I
Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803
[TBL] [Abstract][Full Text] [Related]
14. Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion.
Agrenius V; Chmielewska J; Widström O; Blombäck M
Am Rev Respir Dis; 1989 Nov; 140(5):1381-5. PubMed ID: 2817601
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
16. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.
Idell S; James KK; Levin EG; Schwartz BS; Manchanda N; Maunder RJ; Martin TR; McLarty J; Fair DS
J Clin Invest; 1989 Aug; 84(2):695-705. PubMed ID: 2788176
[TBL] [Abstract][Full Text] [Related]
17. The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.
Tucker TA; Idell S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535429
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
Iakhiaev AV; Nalian A; Koenig K; Idell S
Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
[TBL] [Abstract][Full Text] [Related]
19. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities.
Sitrin RG; Brubaker PG; Fantone JC
Am Rev Respir Dis; 1987 Apr; 135(4):930-6. PubMed ID: 3565941
[TBL] [Abstract][Full Text] [Related]
20. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.
Strange C; Baumann MH; Sahn SA; Idell S
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):508-15. PubMed ID: 7842213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
